Adma Biologics (ADMA) Other Operating Expenses (2011 - 2026)
Adma Biologics' (ADMA) quarterly Other Operating Expenses came in at $1.2 million in Q4 2025, down 9.6% YoY from $1.3 million in Q4 2024, and down 10.15% on a QoQ basis from $1.3 million in Q3 2025.
Adma Biologics (ADMA) Other Operating Expenses (2011 - 2026) Analysis & Trends
Adma Biologics (ADMA) has 13 years of Other Operating Expenses data on file, last reported at $1.2 million in Q4 2025.
- Quarterly Other Operating Expenses fell 9.6% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.0 million (up 7.53% YoY) and the FY2025 annual result came in at $5.0 million, up 7.49% from the prior year.
- Other Operating Expenses retreated to $1.2 million in Q4 2025, from $1.3 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $5.3 million in Q4 2022 to a low of $646000.0 in Q3 2023.
- A 5-year average of $2.3 million and a median of $1.4 million in 2023 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2021 — Other Operating Expenses surged 110.58% — and 2023, when it plunged 87.18%.
- Tracing ADMA's Other Operating Expenses over 5 years: stood at $4.3 million in 2021, then climbed by 23.16% to $5.3 million in 2022, then slumped by 83.44% to $872000.0 in 2023, then surged by 49.31% to $1.3 million in 2024, then retreated by 9.6% to $1.2 million in 2025.
- The last three Other Operating Expenses figures came in at $1.2 million (Q4 2025), $1.3 million (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Adma Biologics | 2.13 Bn | 2.00 Bn | 86.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.08 Mn |
| Dec 31, 2025 | 1.18 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 1.31 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 872,000.00 |
| Sep 30, 2023 | 646,000.00 |
| Jun 30, 2023 | 1.51 Mn |
| Mar 31, 2023 | 1.96 Mn |
| Dec 31, 2022 | 5.27 Mn |
| Sep 30, 2022 | 5.04 Mn |
| Jun 30, 2022 | 4.10 Mn |
| Mar 31, 2022 | 4.15 Mn |
| Dec 31, 2021 | 4.28 Mn |
| Sep 30, 2021 | 3.33 Mn |
| Jun 30, 2021 | 2.98 Mn |